Resmed (RMD) Long-Term Debt Issuances (2011 - 2023)

Resmed's Long-Term Debt Issuances history runs 13 years deep, the most recent figure standing at $105.0 million for Q3 2023.

• Quarterly Long-Term Debt Issuances rose 110.0% year-over-year to $105.0 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $105.0 million (down 90.19% YoY) and the FY2024 annual result came in at $105.0 million, down 90.19% from the prior year.
• Long-Term Debt Issuances was $105.0 million for Q3 2023 at Resmed, down from $1.0 billion in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $1.0 billion in Q4 2022 and bottomed at $10.0 million in Q4 2021.
• A 5-year average of $226.5 million and a median of $139.0 million in 2021 frame the typical range for Long-Term Debt Issuances.
• Annual changes were most pronounced in 2020 — Long-Term Debt Issuances tumbled 90.27% — and 2022, when it jumped 10100.0%.
• Resmed's Long-Term Debt Issuances stood at $165.0 million in 2019, then plunged by 66.67% to $55.0 million in 2020, then plunged by 81.82% to $10.0 million in 2021, then soared by 10100.0% to $1.0 billion in 2022, then slumped by 89.71% to $105.0 million in 2023.
• Business Quant data shows RMD's Long-Term Debt Issuances at $105.0 million in Q3 2023, $1.0 billion in Q4 2022, and $50.0 million in Q3 2022.